Navigating the 2026 ASCO Guideline Update on Managing Thyroid Cancer - CancerNetwork
Navigating the 2026 ASCO Guideline Update on Managing Thyroid Cancer CancerNetwork
Thyroid Cancer News
Identifying Radioiodine-Refractory Disease and Progression Beyond Local Therapy - OncLive
Identifying Radioiodine-Refractory Disease and Progression Beyond Local Therapy OncLive
New discovery explores potential aggressive thyroid cancer treatment - The University of Alabama at Birmingham
New discovery explores potential aggressive thyroid cancer treatment The University of Alabama at Birmingham
Popular rock frontman battling cancer at 62: ‘Putting everything in God’s hands’ - PennLive.com
Popular rock frontman battling cancer at 62: ‘Putting everything in God’s hands’ PennLive.com
The Thyroid Cancer Dilemma: Doing More Isn’t Always Doing Better - Medscape
The Thyroid Cancer Dilemma: Doing More Isn’t Always Doing Better Medscape
New Evidence-Based Recommendations on Thyroid Cancer Treatment – ASCO - Oncodaily
New Evidence-Based Recommendations on Thyroid Cancer Treatment – ASCO Oncodaily
From margins to mandate: Elevating thyroid care in Africa - Economist Impact
From margins to mandate: Elevating thyroid care in Africa Economist Impact
Nation's Largest Thyroid Cancer Center Publishes White Paper Finding No Convincing Evidence That GLP-1 Medications Cause Common Thyroid Cancers - PR Newswire
Nation's Largest Thyroid Cancer Center Publishes White Paper Finding No Convincing Evidence That GLP-1 Medications Cause Common Thyroid Cancers PR Newswire
Polygenic risk scores in thyroid cancer screening, diagnosis and management - Nature
Polygenic risk scores in thyroid cancer screening, diagnosis and management Nature
STRYPER's MICHAEL SWEET On His Thyroid Cancer Battle: 'I'm Just Kind Of Putting Everything In God's Hands' - BLABBERMOUTH.NET
STRYPER's MICHAEL SWEET On His Thyroid Cancer Battle: 'I'm Just Kind Of Putting Everything In God's Hands' BLABBERMOUTH.NET
GLP-1 and Thyroid Cancer Link Lacks Evidence, White Paper Finds - Targeted Oncology
GLP-1 and Thyroid Cancer Link Lacks Evidence, White Paper Finds Targeted Oncology
GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic
GLP-1RA and thyroid cancer: New study suggests detection bias, not causation Mayo Clinic
Thyroid cancer ‘atlas’ points to cell types that contribute to disease progression - Vanderbilt Health News
Thyroid cancer ‘atlas’ points to cell types that contribute to disease progression Vanderbilt Health News
Genetic insights advance understanding of pediatric thyroid cancer - St. Jude Children's Research Hospital
Genetic insights advance understanding of pediatric thyroid cancer St. Jude Children's Research Hospital
Papillary Thyroid Carcinoma: Background, Pathophysiology, Etiology - Medscape
Papillary Thyroid Carcinoma: Background, Pathophysiology, Etiology Medscape
Evaluating Thyroid Cancer Risk After GLP-1 Receptor Agonist Administration - CancerNetwork
Evaluating Thyroid Cancer Risk After GLP-1 Receptor Agonist Administration CancerNetwork
Prevalence and Clinical Relevance of BRAF V600E Mutations in Advanced Thyroid Cancer - OncLive
Prevalence and Clinical Relevance of BRAF V600E Mutations in Advanced Thyroid Cancer OncLive
Thyroid cancer detection and classification using spectral imaging and artificial intelligence - Nature
Thyroid cancer detection and classification using spectral imaging and artificial intelligence Nature
Systemic inflammatory indices comprising monocytes provide a clinical significance for thyroid cancer identification - Nature
Systemic inflammatory indices comprising monocytes provide a clinical significance for thyroid cancer identification Nature
Risk factors for postoperative recurrence of differentiated thyroid cancer: a retrospective study - Nature
Risk factors for postoperative recurrence of differentiated thyroid cancer: a retrospective study Nature
Overexpressed MET drives aggressive thyroid cancer phenotypes and serves as a precision therapeutic target - Nature
Overexpressed MET drives aggressive thyroid cancer phenotypes and serves as a precision therapeutic target Nature
DNMT2 inhibits anaplastic thyroid cancer progression by downregulating 5’tiRNA - Nature
DNMT2 inhibits anaplastic thyroid cancer progression by downregulating 5’tiRNA Nature
NM’s Only Thyroid Cancer Specialty Clinic Expands at UNM SRMC - UNM HSC Newsroom
NM’s Only Thyroid Cancer Specialty Clinic Expands at UNM SRMC UNM HSC Newsroom
Explainable multimodal deep learning for predicting thyroid cancer lateral lymph node metastasis using ultrasound imaging - Nature
Explainable multimodal deep learning for predicting thyroid cancer lateral lymph node metastasis using ultrasound imaging Nature
The Medical Minute: The thyroid cancer symptoms you shouldn’t ignore - Penn State Health News
The Medical Minute: The thyroid cancer symptoms you shouldn’t ignore Penn State Health News
Papillary Thyroid Cancer: Thyroid Lobectomy Provides Comparable Outcomes to Total Thyroidectomy and Radioactive Iodine for Select Patients - Memorial Sloan Kettering Cancer Center
Papillary Thyroid Cancer: Thyroid Lobectomy Provides Comparable Outcomes to Total Thyroidectomy and Radioactive Iodine for Select Patients Memorial Sloan Kettering Cancer Center
Thyroid cancer during pregnancy: Megan’s story - Roswell Park Comprehensive Cancer Center
Thyroid cancer during pregnancy: Megan’s story Roswell Park Comprehensive Cancer Center
Surgeons Confront Misaligned Radioactive Iodine Use in Follicular Thyroid Carcinoma - The American College of Surgeons
Surgeons Confront Misaligned Radioactive Iodine Use in Follicular Thyroid Carcinoma The American College of Surgeons
Gut microbiota and metabolite profiles in thyroid cancer lymph node metastasis: a multi-omics analysis - Nature
Gut microbiota and metabolite profiles in thyroid cancer lymph node metastasis: a multi-omics analysis Nature
Matrix stiffness-driven cytoskeletal remodeling and tumor progression in anaplastic thyroid cancer via integrin-focal adhesion kinase signaling - Nature
Matrix stiffness-driven cytoskeletal remodeling and tumor progression in anaplastic thyroid cancer via integrin-focal adhesion kinase signaling Nature
Clinical significance of level VII lymph node metastasis in papillary thyroid cancer - Nature
Clinical significance of level VII lymph node metastasis in papillary thyroid cancer Nature
What doctors wish patients knew about thyroid cancer - American Medical Association
What doctors wish patients knew about thyroid cancer American Medical Association
Department of Defense Award Supports CU Thyroid Cancer Research - University of Colorado Anschutz
Department of Defense Award Supports CU Thyroid Cancer Research University of Colorado Anschutz
Single status shows age dependent bidirectional effects in differentiated thyroid cancer - Nature
Single status shows age dependent bidirectional effects in differentiated thyroid cancer Nature
Why are thyroid cancer cases increasing across the world? - BBC
Why are thyroid cancer cases increasing across the world? BBC
Tumour genetics and thyroid cancer staging: a balancing act - The Lancet
Tumour genetics and thyroid cancer staging: a balancing act The Lancet
Epigenetic control in thyroid cancer: mechanisms and clinical perspective - Nature
Epigenetic control in thyroid cancer: mechanisms and clinical perspective Nature
METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial–mesenchymal transition - Nature
METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial–mesenchymal transition Nature
At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial) - Journal of Nuclear Medicine
At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial) Journal of Nuclear Medicine
Latest Treatments and Research at MSK To Treat Thyroid Cancer in 2025 - Memorial Sloan Kettering Cancer Center
Latest Treatments and Research at MSK To Treat Thyroid Cancer in 2025 Memorial Sloan Kettering Cancer Center